NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 388 filers reported holding NEKTAR THERAPEUTICS in Q3 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $23,728 | -68.9% | 33,757 | 0.0% | 0.00% | – |
| Q4 2022 | $76,291 | -4.6% | 33,757 | +35.5% | 0.00% | – |
| Q3 2022 | $80,000 | -15.8% | 24,916 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $95,000 | -29.1% | 24,916 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $134,000 | -65.2% | 24,916 | -12.7% | 0.00% | -50.0% |
| Q4 2021 | $385,000 | +14.9% | 28,533 | +53.1% | 0.00% | 0.0% |
| Q3 2021 | $335,000 | +4.7% | 18,638 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $320,000 | -14.2% | 18,638 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $373,000 | -0.5% | 18,638 | -15.5% | 0.00% | 0.0% |
| Q4 2020 | $375,000 | +13.6% | 22,057 | +11.0% | 0.00% | 0.0% |
| Q3 2020 | $330,000 | -28.3% | 19,879 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $460,000 | +61.4% | 19,879 | +24.7% | 0.00% | +33.3% |
| Q1 2020 | $285,000 | +5.2% | 15,946 | +27.1% | 0.00% | +50.0% |
| Q4 2019 | $271,000 | -60.6% | 12,547 | -66.7% | 0.00% | -66.7% |
| Q3 2019 | $687,000 | -48.8% | 37,723 | 0.0% | 0.01% | -45.5% |
| Q2 2019 | $1,342,000 | +2.8% | 37,723 | -2.9% | 0.01% | -8.3% |
| Q1 2019 | $1,305,000 | +8.8% | 38,846 | +6.4% | 0.01% | 0.0% |
| Q4 2018 | $1,200,000 | -43.8% | 36,517 | +4.3% | 0.01% | -33.3% |
| Q3 2018 | $2,135,000 | +24.9% | 35,025 | 0.0% | 0.02% | +20.0% |
| Q2 2018 | $1,710,000 | +49.2% | 35,025 | +224.8% | 0.02% | +50.0% |
| Q1 2018 | $1,146,000 | +113.8% | 10,782 | +20.0% | 0.01% | +100.0% |
| Q4 2017 | $536,000 | +300.0% | 8,982 | +60.3% | 0.01% | +400.0% |
| Q3 2017 | $134,000 | +21.8% | 5,603 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $110,000 | -4.3% | 5,603 | +14.1% | 0.00% | 0.0% |
| Q1 2017 | $115,000 | +91.7% | 4,911 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $60,000 | -28.6% | 4,911 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $84,000 | +35.5% | 4,911 | +12.2% | 0.00% | 0.0% |
| Q2 2016 | $62,000 | +3.3% | 4,376 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $60,000 | -18.9% | 4,376 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $74,000 | +362.5% | 4,376 | +205.4% | 0.00% | – |
| Q3 2015 | $16,000 | +166.7% | 1,433 | +191.3% | 0.00% | – |
| Q2 2015 | $6,000 | +20.0% | 492 | 0.0% | 0.00% | – |
| Q1 2015 | $5,000 | -99.1% | 492 | -99.0% | 0.00% | -100.0% |
| Q4 2013 | $568,000 | +8.6% | 50,000 | 0.0% | 0.02% | +5.6% |
| Q3 2013 | $523,000 | -17.6% | 50,000 | -9.1% | 0.02% | -18.2% |
| Q2 2013 | $635,000 | +5.0% | 55,000 | 0.0% | 0.02% | +4.8% |
| Q1 2013 | $605,000 | +48.3% | 55,000 | 0.0% | 0.02% | +31.2% |
| Q4 2012 | $408,000 | -30.5% | 55,000 | 0.0% | 0.02% | -33.3% |
| Q3 2012 | $587,000 | +32.2% | 55,000 | 0.0% | 0.02% | +20.0% |
| Q2 2012 | $444,000 | +1.8% | 55,000 | 0.0% | 0.02% | 0.0% |
| Q1 2012 | $436,000 | +41.6% | 55,000 | 0.0% | 0.02% | +42.9% |
| Q4 2011 | $308,000 | – | 55,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Strong Tower Advisory Services | 404,972 | $6,913,000 | 4.02% |
| GREAT POINT PARTNERS LLC | 504,691 | $9,064,000 | 2.11% |
| Camber Capital Management LP | 3,750,000 | $67,350,000 | 2.07% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,901,000 | 1.50% |
| Rhenman & Partners Asset Management AB | 950,000 | $17,062,000 | 1.20% |
| MAVERICK CAPITAL LTD | 5,838,426 | $104,858,000 | 1.06% |
| Birchview Capital, LP | 72,000 | $1,293,000 | 0.88% |
| Bellevue Group AG | 4,594,656 | $82,519,000 | 0.84% |
| CM Management, LLC | 50,000 | $898,000 | 0.67% |
| Duquesne Family Office | 1,000,000 | $17,960,000 | 0.58% |